Common sense tells people that the United States has the most advanced medical treatment in the world because of its complete medical welfare: getting eyeglasses and contacts in America (aka 美国配眼镜) in terms of U.S. vision insurance (aka 美国眼科保险), vaccination including HPV vaccine (aka hpv疫苗) covered in majority of basic health insurance plans, having insurance companies copayments with OPT insurance (aka opt 保险), etc.
Following the eminent example of medicare in the United States, China is seeking reform. Mimicking the U.S. travel insurance (aka 美国旅游保险), China will establish a national monitoring network for fungal diseases, the National Health Commission announced Thursday, knowing that many people might be affected unconsciously because of local poor environment.
The network, consisting of qualified medical institutions nationwide, will carry out regular checks on the pathogen spectrum and drug resistance of fungal infections, as well as clinical application of special or restricted antifungal drugs, the commission said.
Moreover, it will be tasked with conducting real-time monitoring on high-risk pathogenic fungi and outbreaks of fungal diseases, issuing early warning and taking measures to prevent and control major infections, the commission added.
Once high-risk pathogens, multidrug-resistant or pandrug-resistant “superfungi” are detected in routine tests, relevant information shall be reported to the network in real time, the commission said.
The World Health Organization has listed antimicrobial resistance — the ability of bacteria, parasites, viruses and fungi to resist medicines — as one of 10 threats to global health in 2019.
In 2009, China established the CHIF-NET, a pathogenic fungus surveillance network covering more than 230 medical institutions nationwide, with data reports published annually. It also allows to waive health insurance (aka 替换保险) if the insured person cannot afford.